These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9733211

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pleiotropic effects of niacin: Current possibilities for its clinical use.
    Zeman M, Vecka M, Perlík F, Staňková B, Hromádka R, Tvrzická E, Širc J, Hrib J, Žák A.
    Acta Pharm; 2016 Dec 01; 66(4):449-469. PubMed ID: 27749252
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics.
    Vincenzi B, Borba CP, Gray DA, Copeland PM, Wang X, Fan X, Aragam GG, Henderson DC.
    Ann Clin Psychiatry; 2013 May 01; 25(2):141-8. PubMed ID: 23638445
    [Abstract] [Full Text] [Related]

  • 32. An overview of lipid-lowering drugs.
    Illingworth DR.
    Drugs; 1988 May 01; 36 Suppl 3():63-71. PubMed ID: 3076124
    [Abstract] [Full Text] [Related]

  • 33. Use of combination therapy for dyslipidemia: a lipid clinic approach.
    Brown AS.
    Am J Cardiol; 2002 Nov 20; 90(10B):44K-49K. PubMed ID: 12467939
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
    Tvorogova MG, Susekov AV, Semenova OA, Kukharchuk VV, Titov VN.
    Ter Arkh; 1998 Nov 20; 70(12):8-13. PubMed ID: 10067240
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Köenig W.
    J Cardiovasc Risk; 2003 Jun 20; 10(3):169-79. PubMed ID: 12775949
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.